Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Psi AG

Start price
Target price
Perf. (%)
€44.50
30.11.21
-
30.11.22
-48.88%
01.12.22

buy
Porr AG ST

Start price
Target price
Perf. (%)
€12.08
29.11.21
€17.50
29.11.22
7.12%
30.11.22

Could be worthwhile Investment >10% per year
Krystal Biotech

Start price
Target price
Perf. (%)
€77.00
29.11.21
-
29.11.22
-19.48%
10.12.21

Probably not worthwhile Investment
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.22
29.11.21
-
29.11.22
-16.11%
12.12.21

Could be worthwhile Investment >10% per year
buy
Borussia Dortmund

Start price
Target price
Perf. (%)
€4.14
29.11.21
-
21.02.25
-17.07%
11.03.24

Could be worthwhile Investment >10% per year
buy
Leoni AG

Start price
Target price
Perf. (%)
€10.59
29.11.21
-
29.11.22
-38.86%
30.11.22

Could be worthwhile Investment >10% per year
Sustainability is important
Medium risks for its business
Increased challenges to pay loans and raise capital
buy
Wacker Neuson NA

Start price
Target price
Perf. (%)
€25.76
29.11.21
€0.000
29.11.22
-35.05%
30.11.22

Known brand
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.32
29.11.21
-
29.11.22
-65.32%
21.07.22

Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.03
29.11.21
-
29.11.22
-21.12%
30.11.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Secunet Security AG

Start price
Target price
Perf. (%)
€405.00
29.11.21
-
29.11.22
-4.81%
12.12.21

Could be worthwhile Investment >10% per year
buy
GFT Technologies AG

Start price
Target price
Perf. (%)
€36.25
28.11.21
€39.00
28.02.22
9.79%
28.02.22

Risky Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Low dividend yield expected
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€17.00
28.11.21
-
28.11.22
7.65%
11.12.21

Could be worthwhile Investment >10% per year
Acorda Therapeutics Cdt

Start price
Target price
Perf. (%)
€2.64
28.11.21
-
28.11.22
-77.46%
29.11.22

Risky Investment
buy
Futura Medical

Start price
Target price
Perf. (%)
€0.36
27.11.21
€0.50
27.11.22
30.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
DBV Technologies S.A.

Start price
Target price
Perf. (%)
€5.24
27.11.21
€8.00
27.11.22
-47.90%
28.11.22

Could be worthwhile Investment >10% per year
buy
Onxeo S.A.

Start price
Target price
Perf. (%)
€0.41
27.11.21
€0.60
27.11.22
-56.65%
28.11.22

Could be worthwhile Investment >10% per year
buy
Sio Gene Therapies Inc.

Start price
Target price
Perf. (%)
€1.39
27.11.21
-
27.11.22
-12.10%
12.12.21

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€28.30
27.11.21
€28.00
27.11.22
-44.88%
30.03.22

Could be worthwhile Investment >10% per year
Very valuable balance sheet
buy
IVU Traffic Technologies AG

Start price
Target price
Perf. (%)
€20.05
27.11.21
-
27.11.22
-19.60%
28.11.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Energiekontor

Start price
Target price
Perf. (%)
€75.50
27.11.21
-
27.11.22
17.22%
28.11.22

EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Good rating
buy
STO SE & Co. KGaA

Start price
Target price
Perf. (%)
€201.00
27.11.21
-
27.11.22
-23.18%
28.11.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
buy
Inovio Pharma

Start price
Target price
Perf. (%)
€6.45
27.11.21
€3.30
27.11.22
-52.69%
12.04.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Nel ASA

Start price
Target price
Perf. (%)
€1.73
27.11.21
€1.20
27.11.22
-2.43%
16.03.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
Hecla Mining Corp.

Start price
Target price
Perf. (%)
€5.04
27.11.21
€4.00
27.11.22
19.54%
14.03.22

Very low/no dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€59.95
27.11.21
€75.00
27.11.22
-29.44%
28.11.22

Could be very worthwhile Investment >20% year
Few uniques